Table 2. Clinical features of samples.
Disease | Gender | Age | Onset age | Duration | Type of DM1 | Cognitive decline |
---|---|---|---|---|---|---|
DM1 | F | 58 | 38 | 20 years | Adult onset | Mild |
F | 66 | 42 | 24 years | Late onset | Mild | |
M | 47 | 12 | 35 years | Juvenile onset | Severe | |
M | 65 | 40 | 25 years | Adult onset | Mild | |
M | 78 | 41 | 37 years | Late onset | Mild | |
M | 57 | 18 | 39 years | Juvenile onset | Mild | |
ALS | F | 53 | N/A | N/A | N/A | Normal |
M | 69 | N/A | N/A | N/A | Normal | |
M | 67 | N/A | N/A | N/A | Normal | |
F | 73 | N/A | N/A | N/A | Normal | |
F | 73 | N/A | N/A | N/A | Normal | |
M | 70 | N/A | N/A | N/A | Normal |
Type of DM1; Juvenile onset (age at onset 10–20 years), Adult onset (age at onset 20–40 years), Late onset (age at onset > 40 years). The degree of cognitive decline was assessed on a three-point scale; Normal, Mild, and Severe.